AlphAIAlphAI — Financial news for AI agents
tradingview.comJUL 311 min read$MED

MED Q2'26 Earnings: EPS estimate is (0.65) USD

Medifast Inc. (MED) is scheduled to report Q2 2026 earnings on Aug. 3 after the market closes, with results expected at 4:05 PM ET. The consensus estimates call for revenue of $72.70 million and EPS of -$0.65 for the quarter, according to the article.

Original reporting
tradingview.com
Published Jul 31, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
MED Q2'26 Earnings: EPS estimate is (0.65) USD — source image
Source · tradingview.com
Decision brief

The 30-second read

$MEDNeutralMed
01

Why it matters

Traders can use the consensus revenue ($72.70M) and EPS (-$0.65) to frame expectations and manage event risk into the after-hours release.

02

Market read

The article is a scheduled earnings preview with consensus estimates, useful for event-risk positioning ahead of the print.

03

What to watch

Actual results could hinge on margin and subscriber retention trends, which are not discussed in the article, so consensus alone may not capture the key drivers.

Relevance 5/10Novelty 5/10Timing: ahead of Aug 03 after-hours earnings release

Background

MEDIFAST (MED) is set to announce Q2'26 earnings on Aug 03 after the market closes.

Company-level read

Ticker impact

$MEDNeutralLow confidence
Context

MEDIFAST is scheduled to report Q2'26 results Aug 03 after the close, with consensus revenue of $72.70M and EPS of -$0.65.

Expected impact

Likely volatility around the Aug 03 after-hours earnings release versus the -$0.65 EPS and $72.70M revenue expectations.

Evidence & confidence

The article provides only the scheduled earnings date and consensus estimates, with no new guidance, results, or surprises disclosed yet.

Market effects

Sector

Limited spillover; this is company-specific pre-earnings positioning for a diet/weight-management retailer.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

If the company has a history of beating or guiding conservatively, the negative EPS consensus may already be priced in, reducing incremental downside risk.

Key entities

  • public_company
    MED

    MEDIFAST Inc., scheduled to report Q2'26 results on Aug 03 after the close.

Read at source← All news

Related articles

AUG 4
$MEDHighAI 9/10

Why Medifast (MED) Stock Is Trading Up Today

Medifast (NYSE: MED) shares rose 37.5% after Q2 results beat expectations and the company issued a stronger full-year outlook. Medifast reported a $0.28 per-share loss versus a $0.65 expected loss, and revenue of $76.38 million. It guided full-year GAAP EPS of $1.00 at the midpoint, versus analyst estimates.

financialcontent.com4 min
AUG 3
$MEDMed

MEDIFAST INC (MED): Results of Operations and Financial Condition

MEDIFAST INC (MED) filed an SEC Form 8-K — Results of Operations and Financial Condition. Medifast Announces Second Quarter 2026 Financial Results August 3, 2026 BALTIMORE – ( BUSINESS WIRE ) — Medifast (NYSE: MED), the health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, today reported results for the second quarter

SEC EDGAR 8-K6 min
SEP 17
$BWINMed

Michael Dell Just Made a $7.7 Billion Bet on This Insurance Stock

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.

yahoo.com2 min
SEP 17
$AMZNMedAI 8/10

Should You Buy Amazon Stock For The Demand AWS Cannot Yet Serve?

Amazon.com (AMZN) stock is down 13% from its 52-week high, despite AWS's 36.7% YOY revenue growth in Q2 2026. AWS's backlog of committed contracts reached $496 billion, with demand outpacing capacity. AWS's operating margin improved 520 basis points YOY, excluding energy contract gains. Management attributes growth to AI workloads and efficient capacity use.

yahoo.com3 min
SEP 17
$ASMLMedAI 8/10

Weakness Is an Opportunity for Long-Term ASML Stock Investors

ASML's High-NA technology is gaining traction among chipmakers like Samsung, Intel, and TSMC, crucial for its long-term outlook. Q2 earnings beat estimates with €7.59 EPS and €9.33B revenue. ASML raised full-year 2026 sales guidance to €43B-€45B. Analysts have a consensus 'Hold' rating, with a mean price target of $2,350.75, implying 56% upside.

yahoo.com3 min